OBJECTIVE: To determine the impact of physiologic changes of pregnancy on pharmacokinetics of chemotherapeutic agents. DESIGN: A preclinical and a clinical case-control trial. SETTING: Institute of Primate Research Nairobi and collaborating hospitals in Belgium, the Netherlands and Czech Republic. POPULATION: Pregnant and nonpregnant women and baboons receiving chemotherapy. METHODS: Chemotherapy pharmacokinetics was compared between the pregnant and nonpregnant state. Standard-dosed chemotherapy regimens were administered in pregnant and nonpregnant baboons/women, followed by serial blood samplings. Drug plasma levels were determined using high performance liquid chromatography and atomic absorption spectrometry. MAIN OUTCOME MEASURES: Are...
BACKGROUND: The paucity of data on fetal effects of prenatal exposure to chemotherapy prompted us to...
Findings of a recent clinical study showed indomethacin has lower plasma levels and higher steady-st...
Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distribute...
OBJECTIVE: To determine the impact of physiologic changes of pregnancy on pharmacokinetics of chemot...
OBJECTIVE: To determine the impact of physiologic changes of pregnancy on pharmacokinetics of chemot...
Item does not contain fulltextBACKGROUND: Based on reassuring short-term foetal and maternal safety ...
Pregnant patients with cancer are increasingly treated with anti-cancer drugs, although the specific...
Background and Objective As a result of changes in physiology during pregnancy, the pharmacokinetics...
Background: Pregnant patients with cancer are increasingly treated with anticancer drugs, although t...
BACKGROUND: In clinical pharmacokinetic (PK) studies, pregnant women are significantly underrepresen...
Use of pharmacotherapy during pregnancy is common and increasing. Physiologic changes during pregnan...
Women are commonly prescribed a variety of medications during pregnancy. As most organ systems are a...
BACKGROUND: Based on reassuring short-term foetal and maternal safety data, there is an increasing t...
OBJECTIVE: The paucity of data on the fetal effects of prenatal exposure to chemotherapy prompted us...
BACKGROUND: The paucity of data on fetal effects of prenatal exposure to chemotherapy prompted us to...
Findings of a recent clinical study showed indomethacin has lower plasma levels and higher steady-st...
Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distribute...
OBJECTIVE: To determine the impact of physiologic changes of pregnancy on pharmacokinetics of chemot...
OBJECTIVE: To determine the impact of physiologic changes of pregnancy on pharmacokinetics of chemot...
Item does not contain fulltextBACKGROUND: Based on reassuring short-term foetal and maternal safety ...
Pregnant patients with cancer are increasingly treated with anti-cancer drugs, although the specific...
Background and Objective As a result of changes in physiology during pregnancy, the pharmacokinetics...
Background: Pregnant patients with cancer are increasingly treated with anticancer drugs, although t...
BACKGROUND: In clinical pharmacokinetic (PK) studies, pregnant women are significantly underrepresen...
Use of pharmacotherapy during pregnancy is common and increasing. Physiologic changes during pregnan...
Women are commonly prescribed a variety of medications during pregnancy. As most organ systems are a...
BACKGROUND: Based on reassuring short-term foetal and maternal safety data, there is an increasing t...
OBJECTIVE: The paucity of data on the fetal effects of prenatal exposure to chemotherapy prompted us...
BACKGROUND: The paucity of data on fetal effects of prenatal exposure to chemotherapy prompted us to...
Findings of a recent clinical study showed indomethacin has lower plasma levels and higher steady-st...
Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distribute...